Details for New Drug Application (NDA): 061894
✉ Email this page to a colleague
The generic ingredient in ILOSONE is erythromycin estolate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin estolate; sulfisoxazole acetyl profile page.
Summary for 061894
Tradename: | ILOSONE |
Applicant: | Lilly |
Ingredient: | erythromycin estolate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061894
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 125MG BASE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION/DROPS;ORAL | Strength | EQ 100MG BASE/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription